Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Angela Baker, Esteban Braggio, Susanna Jacobus, Sungwon Jung, Dirk Larson, Terry Therneau, Angela Dispenzieri, Scott A. Van Wier, Gregory Ahmann, Joan Levy, Louise Perkins, Seungchan Kim, Kimberly Henderson, David Vesole, S. Vincent Rajkumar, Diane F. Jelinek, John Carpten, Rafael Fonseca

Blood (2013) 121 (16): 3147–3152.

https://doi.org/10.1182/blood-2012-07-443606

Published: 2013

Includes: Supplemental data

Journal Articles

Analysis of Serial Patient Samples Reveals a Variety of Clonal Dynamics In Multiple Myeloma

Jonathan J Keats, PhD, Esteban Braggio, Scott Van Wier, Patrick Blackburn, BS, Angela Baker, Michael Barrett, John Carpten, Rafael Fonseca, Keith Stewart, MBA, MB, CHB, P. Leif Bergsagel

Blood (2010) 116 (21): 1923.

https://doi.org/10.1182/blood.V116.21.1923.1923

Published: 2010

Journal Articles

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

Michael A Chapman, Jean-Philippe Brunet, Jonathan J Keats, PhD, Angela Baker, Mazhar Adli, Anna C. Schinzel, Gregory Ahmann, BS, Harview Christina, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, PhD, Daniel Auclair, PhD, William C. Hahn, MD, PhD, Bradley E. Bernstein, MD, Leif Bergsagel, Rafael Fonseca, John Carpten, Jeffrey Trent, Todd R. Golub, MD

Blood (2009) 114 (22): 832.

https://doi.org/10.1182/blood.V114.22.832.832

Published: 2009

Journal Articles

CpG Methylation Profiling in Multiple Myeloma.

Bodour Salhia, PhD, Angela Baker, PhD, Jonathan J Keats, PhD, Gregory Ahmann, BS, Daniel Auclair, PhD, Bunmi Mfuko, Louise M. Perkins, PhD, Joan Levy, PhD, Leif Bergsagel, MD, Rafael Fonseca, MD, John Carpten, PhD

Blood (2009) 114 (22): 604.

https://doi.org/10.1182/blood.V114.22.604.604

Published: 2009

Journal Articles

Loss of KDM6A/UTX Function Is a Common Event in a Mouse Model of Multiple Myeloma, Human Cell Lines and Patients.

Jonathan J Keats, PhD, Marta Chesi, PhD, Esteban Braggio, PhD, Stephan Palmer, Angela Baker, Michael Barrett, PhD, John Carpten, Rafael Fonseca, P. Leif Bergsagel, MD

Blood (2009) 114 (22): 606.

https://doi.org/10.1182/blood.V114.22.606.606

Published: 2009

Journal Articles

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Soledad Molnar, MD, Victor J Jimenez Zepeda, Scott Van Wier, Esteban Braggio, Jonathan Keats, Michael Kuehl, Tammy Price-Troska, Greg Ahmann, Rachel Rempel, Kim Henderson, MD, S. Vincent Rajkumar, MD, Philip. R Greipp, MD, Daniel Auclair, John Carpten, Angela Baker, Keith Stewart, MD, P. Leif Bergsagel, MD, Wee Joo Chng, MD, Rafael Fonseca, MD

Blood (2008) 112 (11): 1663.

https://doi.org/10.1182/blood.V112.11.1663.1663

Published: 2008

Journal Articles

Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease

Michael A Chapman, Jean-Philippe Brunet, Angela Baker, Jonathan Keats, Gregory Ahmann, BS, Anna C Schinzel, PhD, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, PhD, Daniel Auclair, PhD, William C. Hahn, M.D., Ph.D, P. Leif Bergsagel, MD, Rafael Fonseca, MD, John Carpten, Jeffrey Trent, Todd R. Golub, MD

Blood (2008) 112 (11): 497.

https://doi.org/10.1182/blood.V112.11.497.497

Published: 2008

Journal Articles

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Wee J. Chng, MD, Jonathan J. Keats, PhD, Esteben Braggio, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 1476.

https://doi.org/10.1182/blood.V110.11.1476.1476

Published: 2007

Journal Articles

Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma.

Jonathan Keats, PhD, Mike Chapman, PhD, John Carpten, PhD, Wee-Joo Chng, MD, Angela Baker, PhD, Gregory Ahmann, Suzanne Trudel, MD, David Siegel, MD, PhD, S. Vincent Rajkumar, MD, Melissa Alsina, MD, Paul Richardson, MD, Kenneth Anderson, MD, Daniel Auclair, PhD, Louise M. Perkins, PhD, Jeffrey Trent, PhD, Todd R. Golub, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 396.

https://doi.org/10.1182/blood.V110.11.396.396

Published: 2007

Journal Articles

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Wee J. Chng, MD, Tae-Hoon Chung, PhD, Jonathan J. Keats, PhD, Angela Baker, PhD, P. Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2471.

https://doi.org/10.1182/blood.V110.11.2471.2471

Published: 2007

Journal Articles

Comparative High Resolution Array-Based CGH (aCGH) in B-Cell Malignancies.

Esteban Braggio, PhD, Jonathan J. Keats, PhD, Wee-Joo Chng, MD, Victor H. Jimenez, MD, Roelandt Schop, MD, Alexander Sekulik, MD, PhD, Angela Baker, Scott Van Wier, Tammy Price-Troska, Michael Barrett, PhD, John Carpten, PhD, Ellen Remstein, MD, Ahmet Dogan, MD, Leif P. Bergsagel, MD, Rafael Fonseca, MD

Blood (2007) 110 (11): 2479.

https://doi.org/10.1182/blood.V110.11.2479.2479

Published: 2007

Journal Articles

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Wee-Joo Chng, MD, Angela Baker, PhD, Travis Henry, PhD, Tammy Price-Troska, Scott Van Wier, Tae-Hoon Chung, PhD, Kim Henderson, Gregory Ahmann, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2006) 108 (11): 113.

https://doi.org/10.1182/blood.V108.11.113.113

Published: 2006

Journal Articles

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

Blood (2006) 108 (11): 109.

https://doi.org/10.1182/blood.V108.11.109.109

Published: 2006

Journal Articles

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Blood (2006) 108 (11): 3407.

https://doi.org/10.1182/blood.V108.11.3407.3407

Published: 2006

NARROW

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach

Analysis of Serial Patient Samples Reveals a Variety of Clonal Dynamics In Multiple Myeloma

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

CpG Methylation Profiling in Multiple Myeloma.

Loss of KDM6A/UTX Function Is a Common Event in a Mouse Model of Multiple Myeloma, Human Cell Lines and Patients.

Loss of p53 Is a Marker of Progression in Plasma Cell Neoplasias and Is a Negative Prognostic Factor in Relapsed Disease.

Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease

Multiple Myeloma (MM) Is Characterized by Genomic Instability Regardless of Ploidy Categories and Degree of Karyotypic Complexity Is an Important Prognostic Factor.

Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma.

Identification of Survival Critical Genomic Gains or Losses in Myeloma (MM) Using Array-Comparative Genomic Hybridization (aCGH).

Comparative High Resolution Array-Based CGH (aCGH) in B-Cell Malignancies.

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Promiscuous Mutations Frequently Activate the Non-Canonical NFkB Pathway in Multiple Myeloma (MM).

High Resolution Array CGH Identifies TRAF3 as a Novel Tumor Suppressor in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only